Balyasny Asset Management LLC Abbott Laboratories Call Options Transaction History

Balyasny Asset Management LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $6.07 Million - $7.17 Million	60,700 Added 207.88%	89,900 $10.2 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $2.59 Million - $2.89 Million	25,700 Added 734.29%	29,200 $3.03 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $449,032 - $495,936	-4,100 Reduced 53.95%	3,500 $397,000
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $90,190 - $110,400	1,000 Added 15.15%	7,600 $836,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $630,498 - $756,492	6,600 New	6,600 $639,000
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $816,620 - $903,420	-7,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $9.84 Million - $11.6 Million	-93,000 Reduced 93.0%	7,000 $812,000
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $4.81 Million - $5.36 Million	100,000	100,000 $5.34 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.